Rating Change
Morgan Stanley reiterated its Overweight rating on BioNTech SE (NASDAQ:BNTX) on October 07, 2026.
reiterateNASDAQ:BNTX
Morgan Stanley Reiterates Overweight Rating on BioNTech SE (BNTX)
Morgan Stanley reiterated its Overweight rating on BioNTech SE (NASDAQ:BNTX) on October 07, 2026.
At publication ·
What changed
BioNTech SE (NASDAQ:BNTX) · reiterate
- Firm
- Morgan Stanley
- Rating
- Overweight to Overweight
- Price at event
- $95.25
- Market capitalization
- $23.1B
At a glance
Key takeaways
- Morgan Stanley maintained an Overweight rating on BioNTech (BNTX) as of October 7, 2026, with the stock trading at $95.25 and a market cap of $23.1 billion.
Market Context
BioNTech SE operates in the Healthcare sector. The stock currently trades at $95.25 with a market capitalization of $23.1B.
Analyst coverage from Morgan Stanley provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for BioNTech SE.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for BioNTech SE
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Morgan Stanley | Overweight | N/A |
| Sep 08, 2026 | BMO Capital | Market Perform | N/A |
| Aug 31, 2026 | Canaccord Genuity | Buy | N/A |
| Aug 05, 2026 | Evercore ISI Group | Outperform | N/A |
| Aug 05, 2026 | Citigroup | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View BNTX Stock Page
Frequently Asked Questions
What does the Overweight rating mean for BNTX?
A rating of Overweight from Morgan Stanley reflects the analyst's outlook on BioNTech SE (NASDAQ:BNTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BNTX forecast page.
